The effects of venlafaxine on autonomic functions in healthy volunteers

被引:34
|
作者
Siepmann, Timo
Ziemssen, Tjalf
Mueck-Weymann, Michael
Kirch, Wilhelm
Siepmann, Martin
机构
[1] Tech Univ Dresden, Fac Med, Inst Clin Pharmacol, D-01307 Dresden, Germany
[2] Tech Univ Dresden, Fac Med, Autonom Lab, Dept Neurol, D-01307 Dresden, Germany
[3] Tech Univ Dresden, Fac Med, Clin Psychotherapy & Psychosomat Med, D-01307 Dresden, Germany
关键词
D O I
10.1097/jcp.0b013e31815a255b
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Antidepressants that block norepinephrine uptake may cause unwanted effects on autonomic functions such as reduction of heart rate variability. This randomized, double-blind, placebo-controlled study examined the effects of venlafaxine on heart rate variability, vasoconstrictory responses (VRs) of cutaneous blood vessels, and pupillary light reflex in humans. Twelve healthy male subjects aged 23 to 32 years (mean +/- SD, 26 +/- 3 years) orally received 37.5 mg of venlafaxine BID for 7 days and subsequently 75 mg BID for another 7 days. After a 14-day washout phase, placebo was administered to the subjects for 14 days under randomized double-blind crossover conditions. Heart rate variability was diminished, and the dilation phase of VR was prolonged during multiple dosing with venlafaxine (P < 0.05). A significant increase in resting pupil diameter, a decrease in amplitude, an increase in latency, and a shortening of the 33% recovery time of the pupillary light reflex were noted with the drug, whereas no changes were observed under placebo condition. Sustained VR and shortening of the recovery time of the pupillary light reflex are consistent with sympathetic potentiation resulting from noradrenaline reuptake blockade in cutaneous blood vessels and iris. The decrease in amplitude and increase in latency of the pupillary light reflex could be indicative of centrally mediated parasympathetic inhibition.
引用
收藏
页码:687 / 691
页数:5
相关论文
共 50 条
  • [1] The effects of venlafaxine on autonomic functions in healthy subjects
    Siepmann, T.
    Ziemmssen, T.
    Siepmann, M.
    Boecking, W.
    Kirch, W.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2007, 101 (05) : 369 - 369
  • [2] The effects of venlafaxine on cognitive functions and quantitative EEG in healthy volunteers
    Siepmann, T.
    Mueck-Weymann, M.
    Oertel, R.
    Kirch, W.
    Pittrow, D.
    Siepmann, M.
    PHARMACOPSYCHIATRY, 2008, 41 (04) : 146 - 150
  • [3] The effects of sertraline on autonomic functions in healthy volunteers.
    Siepmann, M
    Grossmann, J
    Kirch, W
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (07) : S89 - S89
  • [4] The effects of moclobemide on autonomic and cognitive functions in healthy volunteers
    Siepmann, M
    Handel, J
    Mueck-Weymann, M
    Kirch, W
    PHARMACOPSYCHIATRY, 2004, 37 (02) : 81 - 87
  • [5] The effects of reboxetine on autonomic and cognitive functions in healthy volunteers
    Chalasani N.
    Clark W.S.
    Martin L.G.
    Kamean J.
    Khan M.A.
    Patel N.H.
    Boyer T.D.
    Psychopharmacology, 2001, 157 (2) : 202 - 207
  • [6] The effects of reboxetine on autonomic and cognitive functions in healthy volunteers
    Siepmann, M
    Mück-Weymann, M
    Joraschky, P
    Kirch, W
    PSYCHOPHARMACOLOGY, 2001, 157 (02) : 202 - 207
  • [7] Effects of sertraline on autonomic and cognitive functions in healthy volunteers
    Siepmann, M
    Grossmann, J
    Mück-Weymann, M
    Kirch, W
    PSYCHOPHARMACOLOGY, 2003, 168 (03) : 293 - 298
  • [8] Effects of sertraline on autonomic and cognitive functions in healthy volunteers
    Martin Siepmann
    Jens Grossmann
    Michael Mück-Weymann
    Wilhelm Kirch
    Psychopharmacology, 2003, 168 : 293 - 298
  • [9] The effects of moclobemide on autonomic and cognitive functions in healthy volunteers.
    Handel, J
    Siepmann, M
    Kirch, W
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 58 (07) : S87 - S87
  • [10] Comparison of the effects of modafinil and diphenhydramine on arousal and autonomic functions in healthy volunteers
    Szabadi, E
    Hou, RH
    Langley, RW
    Bradshaw, CM
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (05) : 619 - 620